# RenovoRx, Inc.: filings

RNXT · Nasdaq · CIK 1574094 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rnxt.md) · [Financials](/companies/rnxt/financials.md) · [Filings](/companies/rnxt/filings.md) · [Insiders](/companies/rnxt/insiders.md)

## Reports and events: 89 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 93, 8-K 55, CORRESP 17, 3 16, 10-Q 15, UPLOAD 12, D 7, EFFECT 7, S-8 7, DEF 14A 6, S-3 6, 10-K 5, 424B3 5, SCHEDULE 13G/A 5, 424B5 4, S-1/A 4, SC 13G 3, 3/A 2, DRS/A 2, DRSLTR 2, S-1 2, SCHEDULE 13G 2, 10-K/A 1, 424B4 1, 8-A12B 1, 8-K/A 1, CERT 1, DRS 1, NT 10-K 1, NT 10-Q 1, PRE 14A 1, RW 1, S-8 POS 1, SC 13G/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-20 | 20:05 ET | [8-K](/filings/0001493152-26-039472.md) | 8.01 Other events | 0001493152-26-039472 |
| 2026-08-13 | 20:11 ET | [10-Q](/filings/0001193125-26-349190.md) | Quarterly report, period 2026-06-30 | 0001193125-26-349190 |
| 2026-08-13 | 20:06 ET | [8-K/A](/filings/0001193125-26-349157.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-349157 |
| 2026-08-12 | 20:16 ET | [8-K](/filings/0001193125-26-346894.md) | 9.01 Financial statements and exhibits | 0001193125-26-346894 |
| 2026-08-04 | 20:10 ET | [8-K](/filings/0001493152-26-035995.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-035995 |
| 2026-07-02 | 12:30 ET | [8-K](/filings/0001493152-26-031662.md) | 3.01 Delisting notice | 0001493152-26-031662 |
| 2026-06-30 | 20:55 ET | [8-K](/filings/0001493152-26-031303.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-031303 |
| 2026-05-15 | 21:25 ET | [10-K/A](/filings/0001193125-26-227256.md) | Annual report, amended, period 2025-12-31 | 0001193125-26-227256 |
| 2026-05-14 | 20:19 ET | [10-Q](/filings/0001193125-26-224100.md) | Quarterly report, period 2026-03-31 | 0001193125-26-224100 |
| 2026-05-14 | 20:17 ET | [8-K](/filings/0001193125-26-224080.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-224080 |
| 2026-04-30 | 20:00 ET | [DEF 14A](/filings/0001493152-26-020403.md) | Proxy statement, period 2026-04-30 | 0001493152-26-020403 |
| 2026-03-30 | 21:38 ET | [8-K](/filings/0001493152-26-013653.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-013653 |
| 2026-03-30 | 21:34 ET | [10-K](/filings/0001193125-26-131928.md) | Annual report, period 2025-12-31 | 0001193125-26-131928 |
| 2026-03-27 | 11:00 ET | [8-K](/filings/0001493152-26-013080.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-013080 |
| 2026-03-23 | 11:00 ET | [8-K](/filings/0001493152-26-012058.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-012058 |
| 2026-02-06 | 12:00 ET | [8-K](/filings/0001493152-26-005437.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-005437 |
| 2026-01-02 | 21:10 ET | [8-K](/filings/0001493152-26-000113.md) | 3.01 Delisting notice | 0001493152-26-000113 |
| 2025-11-14 | 21:55 ET | [8-K](/filings/0001493152-25-023604.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-25-023604 |
| 2025-11-13 | 21:21 ET | [8-K](/filings/0001493152-25-022325.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-022325 |
| 2025-11-13 | 21:12 ET | [10-Q](/filings/0001493152-25-022304.md) | Quarterly report, period 2025-09-30 | 0001493152-25-022304 |
| 2025-08-14 | 21:00 ET | [8-K](/filings/0001641172-25-024147.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-024147 |
| 2025-08-14 | 20:08 ET | [10-Q](/filings/0001641172-25-024020.md) | Quarterly report, period 2025-06-30 | 0001641172-25-024020 |
| 2025-06-25 | 21:17 ET | [8-K](/filings/0001641172-25-016512.md) | 5.07 Shareholder vote results | 0001641172-25-016512 |
| 2025-05-15 | 20:15 ET | [10-Q](/filings/0001641172-25-010935.md) | Quarterly report, period 2025-03-31 | 0001641172-25-010935 |
| 2025-05-15 | 20:07 ET | [8-K](/filings/0001641172-25-010895.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-010895 |
| 2025-04-30 | 21:13 ET | [DEF 14A](/filings/0001641172-25-007884.md) | Proxy statement, period 2025-04-30 | 0001641172-25-007884 |
| 2025-04-01 | 13:00 ET | [8-K](/filings/0001641172-25-002009.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-002009 |
| 2025-04-01 | 00:39 ET | [10-K](/filings/0001641172-25-001932.md) | Annual report, period 2024-12-31 | 0001641172-25-001932 |
| 2025-02-10 | 14:14 ET | [8-K](/filings/0001493152-25-005559.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-005559 |
| 2024-11-14 | 13:30 ET | [8-K](/filings/0001493152-24-045373.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-045373 |
| 2024-11-13 | 21:15 ET | [10-Q](/filings/0001493152-24-045137.md) | Quarterly report, period 2024-09-30 | 0001493152-24-045137 |
| 2024-09-25 | 20:10 ET | [8-K](/filings/0001493152-24-038108.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-038108 |
| 2024-08-16 | 20:05 ET | [8-K](/filings/0001493152-24-032812.md) | 4.01 Change of auditor | 0001493152-24-032812 |
| 2024-08-13 | 21:03 ET | [10-Q](/filings/0001493152-24-031675.md) | Quarterly report, period 2024-06-30 | 0001493152-24-031675 |
| 2024-06-07 | 20:41 ET | [8-K](/filings/0001493152-24-023128.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-24-023128 |
| 2024-05-10 | 21:21 ET | [10-Q](/filings/0001493152-24-018704.md) | Quarterly report, period 2024-03-31 | 0001493152-24-018704 |
| 2024-05-03 | 21:00 ET | [8-K](/filings/0001493152-24-017745.md) | 4.01 Change of auditor; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-24-017745 |
| 2024-04-30 | 20:30 ET | [DEF 14A](/filings/0001493152-24-017244.md) | Proxy statement, period 2024-04-30 | 0001493152-24-017244 |
| 2024-04-18 | 20:15 ET | [8-K](/filings/0001493152-24-015192.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-015192 |
| 2024-04-16 | 12:00 ET | [8-K](/filings/0001493152-24-014742.md) | 8.01 Other events | 0001493152-24-014742 |
| 2024-04-15 | 13:00 ET | [8-K](/filings/0001493152-24-014559.md) | 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-014559 |
| 2024-04-09 | 20:15 ET | [8-K](/filings/0001493152-24-014069.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-014069 |
| 2024-04-01 | 20:05 ET | [10-K](/filings/0001493152-24-012357.md) | Annual report, period 2023-12-31 | 0001493152-24-012357 |
| 2024-03-14 | 20:53 ET | [8-K](/filings/0001493152-24-009978.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-24-009978 |
| 2024-02-23 | 22:00 ET | [8-K](/filings/0001493152-24-007693.md) | 3.01 Delisting notice; 5.02 Departure or appointment of officers or directors | 0001493152-24-007693 |
| 2024-02-09 | 21:30 ET | [8-K](/filings/0001493152-24-005711.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-24-005711 |
| 2024-01-29 | 14:06 ET | [8-K](/filings/0001493152-24-004083.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-004083 |
| 2024-01-02 | 13:30 ET | [8-K](/filings/0001493152-24-000024.md) | 8.01 Other events | 0001493152-24-000024 |
| 2023-12-18 | 21:15 ET | [8-K](/filings/0001493152-23-045272.md) | 5.07 Shareholder vote results | 0001493152-23-045272 |
| 2023-11-27 | 18:23 ET | [DEF 14A](/filings/0001493152-23-042751.md) | Proxy statement, period 2023-11-27 | 0001493152-23-042751 |

Page 1 of 2. [Older](/companies/rnxt/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:13 ET. No prices; not investment advice.